915 abstracts found.



Results filter

Development of novel imaging methods in mouse cancer models

Year:

Session type:

Kevin Brindle1

1University of Cambridge, Cambridge, UK


Introduction: Integration between oncology and palliative care

Year:

Session type:

Irene Higginson1

1King’s College London, London, UK


CRAd improve gene replication efficiency and cancer killing effect of E1-deleted adenovirus including killing gene in head and neck cancer cell line

Year:

Session type:

Seon-Hui Shim, Myung-Whun Sung

Cancer Research Institute, Seoul, Republic Of Korea


Interactions between RhoA-GTPase and cGMP/cAMP ignalling influence both the vascular disrupting and anti-angiogenic activities of combretastatin A-4-Phosphate

Year:

Session type:

Chryso Kanthou, Gillian Tozer

University of Sheffield, UK


Changes in Ca-125 relative to response following treatment with Pegylated Liposomal Doxorubicin (Caelyx®) in ovarian carcinoma

Year:

Session type:

Richard Turkington, Paula Scullin, Joanne Millar

Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK


Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates Akt activation and potentiates mTOR blockade in breast cancer cells

Year:

Session type:

Matthew Roforth, Chalet Tan

Mercer University, Atlanta, USA


The social impact of cancer on people of south Asian origin: staff and patient interview studies

Year:

Session type:

Naheed Hanif, Nimarta Dharni, Chris Bradley, Karl Atkin, Sangeeta Chattoo, Galina Velikova, Dan Stark, Penny Wright

Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford Teaching Hospitals Foundation Trust, UK


Isolation of novel functional anti-cancer antibodies by phage display

Year:

Session type:

Sandrine Guillard, Steven Rust, David Lowne, Arthur Lewis, Ralph Minter, Lutz Jermutus

Medimmune, Cambridge, UK


Antibodies: tools for research of and treatment of cancer

Year:

Session type:

Theresa Street

Cancer Research UK, London, UK


Glioma stem cell lines configured for patient-specific chemical genetic screens

Year:

Session type:

Steven Pollard1, Koichi Yoshikawa2, Ian Clarke2, Austin Smith1, Peter Dirks2

1Wellcome Trust Centre for Stem Cell Research, University of Cambridge, UK, 2The Hospital for Sick Children, University of Toronto, Canada


Page 1 of 921...25...Last »